Clinical Trial Update: Adjuvant Stereotactic Fractionated Radiotherapy to the Resection Cavity in Recurrent Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Technical University of Munich | Conditions: Glioblastoma | Phase 2 | Status: UNKNOWN